Abstract
The study aimed to develop prediction algorithms for hypertensive disorders based on multivariate analysis of factors from the maternal history and compare the estimated performance of such algorithms in the prediction of early preeclampsia (PE), late-PE and gestational hypertension (GH) with that recommended by the National Institute for Clinical Excellence (NICE). Logistic regression analysis was used to determine which of the maternal characteristics and history had significant contribution in predicting early-PE, late-PE and GH. There were 37 cases with early-PE, 128 with late-PE, 140 with GH and 8061 cases that were unaffected by PE or GH. Predictors of early-PE were Black race, chronic hypertension, prior PE and use of ovulation drugs. Predictors of late-PE and GH were increased maternal age and body mass index, and family history or history of PE. Additionally, late-PE was more common in Black, Indian and Pakistani women. The detection rates of early-PE, late-PE and GH in screening by maternal factors were 37.0, 28.9 and 20.7%, respectively, for a 5% false positive rate. Screening as suggested by NICE would have resulted in a false positive rate of 64.1% with detection rates of 89.2, 93.0 and 85.0% for early-PE, late-PE and GH, respectively. Meaningful screening for hypertensive disorders in pregnancy by maternal history necessitates the use of algorithms derived by logistic regression analysis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
World Health Organization. Make Every Mother and Child Count. World Health Report 2005. World Health Organization: Geneva, Switzerland, 2005.
Lewis G (ed). The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer—2003–2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. CEMACH: London, United Kingdom, 2007.
Confidential Enquiry into Maternal and Child Health (CEMACH). Perinatal Mortality 2006: England, Wales and Northern Ireland. CEMACH: London, United Kingdom, 2008.
American College of Obstetricians and Gynecologists Committee on Practice Bulletins–Obstetrics. ACOG practice bulletin: diagnosis and management of pre-eclampsia and eclampsia: number 33, January 2002. Obstet Gynecol 2002; 99: 159–167.
Antenatal care: routine care for the healthy pregnant woman. Clinical Guideline. National Collaborating Centre for Women's and Children's Health. Commissioned by the National Institute for Clinical Excellence. RCOG Press: London, United Kingdom, 2008.
Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B . The frequency and severity of placental findings in women with pre-eclampsia are gestational age dependent. Am J Obstet Gynecol 2003; 189: 1173–1177.
Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD . Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG 2006; 113: 580–589.
Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH . Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2007; 30: 742–749.
Yu CK, Khouri O, Onwudiwe N, Spiliopoulos Y, Nicolaides KH . Fetal Medicine Foundation Second-Trimester Screening Group. Prediction of pre-eclampsia by uterine artery Doppler imaging: relationship to gestational age at delivery and small-for-gestational age. Ultrasound Obstet Gynecol 2008; 31: 310–313.
Witlin GA, Saade GR, Mattar FM, Sibai BM . Predictors of neonatal outcome in women with severe pre-eclampsia or eclampsia between 24 and 33 weeks’ gestation. Am J Obstet Gynecol 2000; 182: 607–611.
Irgens HU, Reisaeter L, Irgens LM, Lie RT . Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001; 323: 1213–1217.
Khong TY, De Wolf F, Robertson WB, Brosens I . Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. BJOG 1986; 93: 1049–1059.
Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH . UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998; 352: 343–346.
Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH . Screening for trisomy 21 by maternal age, fetal NT, free ß hCG and PAPP-A. Ultrasound Obstet Gynecol 2008; 31: 618–624.
Davey DA, MacGillivray I . The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892–898.
Duckitt K, Harrington D . Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005; 330: 565–572.
Eskenazi B, Fenster L, Sidney S . A multivariate analysis of risk factors for preeclampsia. JAMA 1991; 266: 237–241.
Lie RT, Rasmussen S, Brunborg H, Gjessing H, Lie-Nielsen E, Irgens LM . Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ 1998; 316: 1343–1347.
Mostello D, Catlin TK, Roman L, Holcomb W, Leet T . Preeclampsia in the parous woman: who is at risk? Am J Obstet Gynecol 2002; 187: 425–429.
Stone JL, Lockwood CJ, Berkowitz GS, Alvarez M, Lapinski R, Berkowitz RL . Risk factors for severe preeclampsia. Obstet Gynecol 1994; 83: 357–361.
Odegard R, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R . Risk factors and clinical manifestations of pre-eclampsia. BJOG 2000; 107: 1410–1416.
Cincotta RB, Brennecke SP . Family history of pre-eclampsia as a predictor for pre-eclampsia in primigravidas. Int J Gynecol Obstet 1998; 60: 23–27.
Arngrimsson R, Bjornsson S, Geirsson R, Bjornsson H, Walker J, Snaedal G . Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. BJOG 1990; 97: 762–769.
Conde-Agudelo A, Belizan JM . Risk factors for pre-eclampsia in a large cohort of Latin American and Caribbean women. BJOG 2000; 107: 75–83.
Catov JM, Ness RB, Kip KE, Olsen J . Risk of early or severe preeclampsia related to pre-existing conditions. Int J Epidemiol 2007; 36: 412–419.
Maman E, Lunenfeld E, Levy A, Vardi H, Potashnik G . Obstetric outcome of singleton pregnancies conceived by in vitro fertilization and ovulation induction compared with those conceived spontaneously. Fertil Steril 1998; 70: 240–245.
Shevell T, Malone F, Vidaver J, Porter TF, Luthy DA, Comstock CH et al. The FASTER Research Consortium. Assisted reproductive technology and pregnancy outcome. Obstet Gynecol 2005; 106: 1039–1045.
Jackson RA, Gibson KA, Wu YW, Croughan MS . Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol 2004; 103: 551–563.
Trogstad L, Magnus P, Moffett A, Stoltenberg C . The effect of recurrent miscarriage and infertility on the risk of pre-eclampsia. BJOG 2009; 116: 108–113.
Lambert-Messerlian G, Dugoff L, Vidaver J, Canick JA, Malone FD, Ball RH et al. First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study. Prenat Diagn 2006; 26: 672–678.
Poon LCY, Maiz N, Valencia C, Plasencia W, Nicolaides KH . First-trimester maternal serum PAPP-A and preeclampsia. Ultrasound Obstet Gynecol 2008; 33: 23–33.
Mittendorf R, Lain KY, Williams MA, Walker CK . Preeclampsia. A nested, case-control study of risk factors and their interactions. J Reprod Med 1996; 41: 491–496.
O’Brien TE, Ray JG, Chan W-S . Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 2003; 14: 368–374.
Sibai BM, Ewell M, Levine RJ, Klebanoff MA, Esterlitz J, Catalano PM et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1997; 177: 1003–1010.
Sebire NJ, Jolly M, Harris JP, Wadsworth J, Joffe M, Beard RW et al. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab 2001; 25: 1175–1182.
Bianco AT, Smillen SW, Davis Y, Lopez S, Lapinski R, Lockwood CJ . Pregnancy outcome and weight gain recommendations for the morbidity obese woman. Obstet Gynecol 1998; 91: 97–102.
Saftlas AF, Olson DR, Franks AI, Atrash HK, Pokras R . Epidemiology of preeclampsia and eclampsia in the United stets, 1979-1986. Am J Obstet Gynecol 1990; 163: 360–365.
D’Anna R, Baviera G, Corrado F, Giordano D, De Vivo A, Nicocia G et al. Adiponectin and insulin resistance in early- and late-onset pre-eclampsia. BJOG 2006; 113: 1264–1269.
Fulop T, Larbi A, Douziech N . Insulin receptor and ageing. Pathol Biol (Paris) 2003; 51: 574–580.
Kolovou GD, Bilianou HG . Influence of aging and menopause on lipids and lipoproteins in women. Angiology 2008; 49 (2 Suppl): 54S–57S.
Ramaraj R, Chellappa P . Cardiovascular risk in South Asians. Postgrad Med J 2008; 84: 518–523.
Cappuccio FP . Ethnicity and cardiovascular risk: variations in people of African ancestry and South Asian origin. J Hum Hypertens 1997; 11: 571–576.
Cappuccio FP, Cook DG, Atkinson RW, Strazzullo P . Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart 1997; 78: 555–563.
Poon LC, Kametas NA, Pandeva I, Valencia C, Nicolaides KH . Mean arterial pressure at 11(+0) to 13(+6) weeks in the prediction of preeclampsia. Hypertension 2008; 51: 1027–1033.
Akolekar R, Zaragoza E, Poon LCY, Pepes S, Nicolaides KH . Maternal serum placental growth factor (PlGF) at 11+0 to 13+6 weeks of gestation in the prediction of preeclampsia. Ultrasound Obstet Gynecol 2008; 32: 732–739.
Acknowledgements
This study was supported by a grant from the Fetal Medicine Foundation (UK Charity No: 1037116). This study was approved by King's College Hospital Ethics Committee (02-03-033).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Poon, L., Kametas, N., Chelemen, T. et al. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens 24, 104–110 (2010). https://doi.org/10.1038/jhh.2009.45
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2009.45
Keywords
This article is cited by
-
Novel Associations Between Mid-Pregnancy Cardiovascular Biomarkers and Preeclampsia: An Explorative Nested Case-Control Study
Reproductive Sciences (2024)
-
Pre-eclampsia
Nature Reviews Disease Primers (2023)
-
Die ältere Schwangere über 40
Gynäkologische Endokrinologie (2020)
-
Postpartum Hypertension
Current Hypertension Reports (2020)
-
External validation of prognostic models predicting pre-eclampsia: individual participant data meta-analysis
BMC Medicine (2020)